Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000626119 | SCV000746746 | likely benign | not provided | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004659127 | SCV005148300 | uncertain significance | not specified | 2024-05-26 | criteria provided, single submitter | clinical testing | The c.478G>A (p.E160K) alteration is located in exon 4 (coding exon 4) of the PNCK gene. This alteration results from a G to A substitution at nucleotide position 478, causing the glutamic acid (E) at amino acid position 160 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |